February 24, 2026

What Is Causing a Rise in Early-Onset Gastrointestinal Cancers, Including Pancreatic Cancer?

Although it’s been widely reported for years that colorectal cancer incidence has been increasing among younger adults under age 50 by between 1% and 2% annually since the mid-1990s,1 two new studies ...

The ASCO Post

February 05, 2026

WHO Analysis Finds Nearly 40% of Global Cancer Cases Attributable to Modifiable Risk Factors

“This landmark study is a comprehensive assessment of preventable cancer worldwide, incorporating for the first time infectious causes of cancer alongside behavioral, environmental, and occupational r...

The ASCO Post

February 05, 2026

WHO Analysis Finds Nearly 40% of Global Cancer Cases Attributable to Modifiable Risk Factors

“This landmark study is a comprehensive assessment of preventable cancer worldwide, incorporating for the first time infectious causes of cancer alongside behavioral, environmental, and occupational r...

The ASCO Post

January 15, 2026

Final Overall Survival Confirms Benefit of Durvalumab Plus FLOT in Resectable Gastric and Gastroesophageal Junction Adenocarcinomas

The addition of the PD-L1–targeting monoclonal antibody durvalumab to conventional perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) resulted in a statistical...

The ASCO Post

October 22, 2025

Obesity-Related Cancers Are Rising Among Both Younger and Older Adults Worldwide

A surveillance study across 42 countries evaluating cancer incidence among younger and older adults has found that other than colorectal cancer, increases occurred in both age groups, and all were rel...

The ASCO Post

September 24, 2025

Endoscopic Surveillance for Barrett’s Esophagus: Two-Year Results

"The burden of Barrett’s surveillance on endoscopic resources can be significant, and it may be appropriate to lengthen the surveillance interval or consider offering at-need endoscopy to well-informed patients."

MDSpire News

June 27, 2025

DDW 2025: Genetic Mutations Linked to Worse Stomach Cancer Outcomes

Researchers analyzed 21 genes in tumor samples from 87 patients who had undergone surgery and chemotherapy for gastric cancer and then tracked how the mutations related to survival. 

The ASCO Post

May 05, 2025

Early-Stage Stomach Cancer Diagnoses on the Rise

Stomach cancers are increasingly being diagnosed at less advanced, more treatable stages—a shift that marks major progress in detecting one of the deadliest forms of cancer, according to a study prese...

The ASCO Post

December 19, 2024

Ramucirumab/Paclitaxel as Switch Maintenance in Advanced HER2-Negative Gastric/Gastroesophageal Junction Cancer

In an Italian phase III study (ARMANI) reported in The Lancet Oncology, Randon et al found that switch maintenance with ramucirumab/paclitaxel was associated with significantly improved progression-fr...

The ASCO Post

December 19, 2024

Ramucirumab/Paclitaxel as Switch Maintenance in Advanced HER2-Negative Gastric/Gastroesophageal Junction Cancer

In an Italian phase III study (ARMANI) reported in The Lancet Oncology, Randon et al found that switch maintenance with ramucirumab/paclitaxel was associated with significantly improved progression-fr...

The ASCO Post